Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: New York 23 trials found
New Search
Filter
Trial Phase
Study Type
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
NAINTERVENTIONAL Newark, New Jersey
RECRUITING
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Glendale, California +4 more
RECRUITING
Exercise to Improve Brain Health in Older African Americans
PHASE2INTERVENTIONAL Newark, New Jersey
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
N/AOBSERVATIONAL Nutley, New Jersey
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2, PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
NAINTERVENTIONAL Hackensack, New Jersey
RECRUITING
Open-label Extension Study in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
Trial-Ready Cohort-Down Syndrome (TRC-DS)
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
PHASE2INTERVENTIONAL Englewood, New Jersey
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Tau Networks in Psychotic Alzheimer's Disease
N/AOBSERVATIONAL Manhasset, New York
RECRUITING
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
PHASE2INTERVENTIONAL New Brunswick, New Jersey
RECRUITING
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
PHASE3INTERVENTIONAL Anaheim, California +4 more
RECRUITING
Neurologic Stem Cell Treatment Study
NAINTERVENTIONAL Westport, Connecticut +2 more
RECRUITING
Filter Trials
Trial Phase
Study Type